Climb Bio to Present at Upcoming Investor Conferences in September 2025.
ByAinvest
Monday, Aug 25, 2025 7:03 am ET1min read
CLYM--
The Cantor Global Healthcare Conference will be held in New York on Friday, September 5, 2025, featuring a fireside chat and one-on-one investor meetings. The Baird Global Healthcare Conference will take place on Tuesday, September 9, 2025, also in New York, with a similar format. The Morgan Stanley Annual Global Healthcare Conference, scheduled for Wednesday, September 10, 2025, will consist of one-on-one meetings only. The Stifel Virtual Immunology and Inflammation Forum, also on Wednesday, September 10, 2025, will feature a presentation and one-on-one investor meetings [2].
Climb Bio will provide live webcasts of these events through its investor relations website, with replays available for 30 days after each event. The webcasts can be accessed via the "Investors and News" section of the Climb Bio website [1].
Climb Bio's pipeline includes budoprutug, an anti-CD19 monoclonal antibody with demonstrated B-cell depletion potential, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy [1].
References
[1] https://www.stocktitan.net/news/CLYM/climb-bio-to-present-at-upcoming-september-2025-investor-he5rx80touud.html
[2] https://www.globenewswire.com/news-release/2025/08/25/3138331/0/en/Climb-Bio-to-Present-at-Upcoming-September-2025-Investor-Conferences.html
Climb Bio announced its executive team will participate in upcoming investor conferences, including the Cantor Global Healthcare Conference, Baird Global Healthcare Conference, Morgan Stanley Annual Global Healthcare Conference, and Stifel Virtual Immunology and Inflammation Forum. The events will be held in New York and virtually between September 5 and September 10. The live webcasts will be available on Climb Bio's website.
Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company focused on immune-mediated disease therapeutics, has announced its participation in four major investor conferences in September 2025. The company will attend the Cantor Global Healthcare Conference, Baird Global Healthcare Conference, Morgan Stanley Annual Global Healthcare Conference, and Stifel Virtual Immunology and Inflammation Forum [1].The Cantor Global Healthcare Conference will be held in New York on Friday, September 5, 2025, featuring a fireside chat and one-on-one investor meetings. The Baird Global Healthcare Conference will take place on Tuesday, September 9, 2025, also in New York, with a similar format. The Morgan Stanley Annual Global Healthcare Conference, scheduled for Wednesday, September 10, 2025, will consist of one-on-one meetings only. The Stifel Virtual Immunology and Inflammation Forum, also on Wednesday, September 10, 2025, will feature a presentation and one-on-one investor meetings [2].
Climb Bio will provide live webcasts of these events through its investor relations website, with replays available for 30 days after each event. The webcasts can be accessed via the "Investors and News" section of the Climb Bio website [1].
Climb Bio's pipeline includes budoprutug, an anti-CD19 monoclonal antibody with demonstrated B-cell depletion potential, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy [1].
References
[1] https://www.stocktitan.net/news/CLYM/climb-bio-to-present-at-upcoming-september-2025-investor-he5rx80touud.html
[2] https://www.globenewswire.com/news-release/2025/08/25/3138331/0/en/Climb-Bio-to-Present-at-Upcoming-September-2025-Investor-Conferences.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
Comments
No comments yet